Bloomberg
😐 Neutral
Island Pharma Jumps After Emergency-Use Approval for Ebola Drug
Australia’s Island Pharmaceuticals Ltd. surged as much as 47% after saying its experimental antiviral galidesivir had secured regulatory and ethics approvals for emergency use in patients with the Bundibugyo strain of Ebola in Uganda.
Related Articles You May Like
Related News
Comments (0)
Leave a Comment
No comments yet. Be the first to comment!